Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment

BACKGROUND: Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (RA) and primary Sjögren’s syndrome (pSS). However, little is known whether the diseases influence pneumococcal vaccine response. This study aimed to investigate antibody response and functionality of antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nived, Per, Saxne, Tore, Geborek, Pierre, Mandl, Thomas, Skattum, Lillemor, Kapetanovic, Meliha C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390610/
https://www.ncbi.nlm.nih.gov/pubmed/30886963
http://dx.doi.org/10.1186/s41927-018-0019-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390610/
https://www.ncbi.nlm.nih.gov/pubmed/30886963
http://dx.doi.org/10.1186/s41927-018-0019-6

Ejemplares similares